
Teva Pharmaceutical (TEVA) Market Capitalization Overview
Market Cap: $23.49B as of Oct 31, 2025
$23.49B
Past Month+$493.15M (2.14%)
As of Oct 31, 2025, Teva Pharmaceutical (TEVA) has a market capitalization of $23.49B. Over the past 30 days, its market cap has increased by 6.99%, while in the last 12 months, it has decreased by -6.07%.
Market capitalization represents the total value of Teva Pharmaceutical as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Teva Pharmaceutical (TEVA) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Teva Pharmaceutical (TEVA) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Teva Pharmaceutical as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Teva Pharmaceutical (TEVA) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Teva Pharmaceutical (TEVA) helps investors assess the company's size and compare it with competitors for better investment decisions.
Teva Pharmaceutical (TEVA) Market Cap & Key Trends
See Teva Pharmaceutical’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Teva Pharmaceutical (TEVA)
Order type
Buy in
Order amount
Est. shares
0 shares
Teva Pharmaceutical (TEVA) Market Cap History
| Date | Market Cap | Change | 
|---|---|---|
| Oct 1, 2025 | $23.01B | +6.99% | 
| Sep 2, 2025 | $21.51B | +21.91% | 
| Aug 1, 2025 | $17.64B | -7.57% | 
| Jul 1, 2025 | $19.09B | -3.51% | 
| Jun 2, 2025 | $19.78B | +10.50% | 
| May 1, 2025 | $17.90B | +2.16% | 
| Apr 1, 2025 | $17.52B | -4.44% | 
| Mar 3, 2025 | $18.34B | -6.87% | 
| Feb 3, 2025 | $19.69B | -18.54% | 
| Jan 2, 2025 | $24.17B | +28.11% | 
Teva Pharmaceutical (TEVA) End of Year Market Cap History
| Date | Market Cap | Change | 
|---|---|---|
| 2025 | $23.49B | -6.07% | 
| 2024 | $25.01B | +113.70% | 
| 2023 | $11.71B | +15.54% | 
| 2022 | $10.13B | +14.64% | 
| 2021 | $8.84B | -16.46% | 
| 2020 | $10.58B | — | 
FAQs About Teva Pharmaceutical (TEVA) Market Cap
As of Oct 31, 2025, the market capitalization of Teva Pharmaceutical (TEVA) is $23.49B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Teva Pharmaceutical’s market capitalization has increased by 2.14%, changing from $22.99B to $23.49B as of Oct 31, 2025.
In the last 3 months, Teva Pharmaceutical’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Teva Pharmaceutical’s market capitalization increased from $11.71B in January to $25.01B in December, reflecting a 113.7% change.
In the past five years, Teva Pharmaceutical (TEVA) has had a compound annual growth rate (CAGR) of 18.78% in market capitalization. This means its market cap has grown at an average rate of 18.78% per year.